Clinical Trials in Nashville

Showing 3301-3320 of 15,379 trials

To Assess the Safety, Tolerability and Efficacy of Itacitinib Immediate Release Tablets in Participants With Primary or Secondary Myelofibrosis Who Have Received Prior Ruxolitinib and/or Fedratinib Monotherapy (LIMBER-213)

NCT04629508

This is a 2-part study. In Part 1, participants will be dosed at 2 different dose levels in order to select the RP2D for Part 2 of the study.

MyelofibrosisPolycythemia VeraThrombocythemia

Incyte Corporation4 participantsStarted Jul 2021

New Orleans, Louisiana, United States • Bethesda, Maryland, United States • Kansas City, Missouri, United States +18 more locations

COMPLETEDPhase 3< 1 mile

Treatment of GVHD in Hematopoietic Stem Cell Transplant (HSCT) Recipients Using AAT Plus Corticosteroids (CS) Compared With Corticosteroids Alone

NCT04167514

Study CSL964\_5001 will investigate the efficacy of AAT with corticosteroids compared with corticosteroids alone as first line therapy for patients with high-risk acute GVHD

Graft Versus Host Disease (GVHD)

CSL Behring136 participantsStarted Jan 2020

Stanford, California, United States • Gainesville, Florida, United States • Tampa, Florida, United States +22 more locations

To Assess the Safety, Tolerability and Efficacy of Itacitinib Immediate Release Tablets in Participants With Primary or Secondary Myelofibrosis Who Have Received Prior Ruxolitinib and/or Fedratinib Monotherapy (LIMBER-213)

Treatment of GVHD in Hematopoietic Stem Cell Transplant (HSCT) Recipients Using AAT Plus Corticosteroids (CS) Compared With Corticosteroids Alone

Find Trials by Condition in Nashville

HPC Offered for PRESERVE Expansion

Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease

Long-Term Evaluation of BIIB067 (Tofersen)

A Study of LY3549492 in Healthy Weight Adult Participants

A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

Saroglitazar Magnesium 4 mg for Nonalcoholic Fatty Liver Disease (NAFLD) in People Living With HIV in the US

Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer

Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMD

A Study of the Safety, Tolerability, and Pharmacokinetics of Dolutegravir in Neonates Exposed to HIV-1

HIV/STD Risk and PrEP Implementation Messaging Among Gay, Bisexual, and Other Men Who Have Sex With Men

INSPIRIS RESILIA Aortic Valve, Valve-in-Valve Surveillance Study

A Study Investigating DNA-damage Response Agents in Molecularly Altered Advanced Cancer

A Study of Setanaxib Co-Administered With Pembrolizumab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)

MR Image Synthesis With Low Gadobutrol Dose and AI

Post-approval Study of New Enrolment Patients Undergoing Bilateral Treatment With the VisuMax SMILE Procedure

Effect of Evolocumab on Saphenous Vein Graft Patency Following Coronary Artery Bypass Surgery

Telehealth 2.0: Evaluating Effectiveness and Engagement Strategies for CPT-Text for PTSD

Sub-study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Nirogacestat, Pomalidomide, and Dexamethasone in Participants With RRMM